Our Team

Jacob Donoghue, PhD

CEO & Co-Founder

Jake translates scientific innovation into clinical interventions. He recently completed his PhD in neuroscience from MIT, leading research into the effects of neuroactive compounds on brain network activity. His published works span epilepsy, cognition, brain-computer interfaces, and machine learning methods for quantifying pharmacological effects on neural activity.

Jarrett Revels

CTO & Co-Founder

Jarrett has spent his career dedicated to making good science go farther, faster. Prior to co-founding Beacon, his research at MIT spawned new compiler techniques now leveraged by many modern machine learning frameworks. Today, his open-source work continues to help thousands of scientists and engineers carry out new simulations and explore new ideas.

Brandon Westover, MD PhD

Co-Founder

Brandon is Associate Professor of Neurology at Harvard Medical School, where he directs the MGH Critical Care EEG Monitoring Service and the MGH Clinical Data AI Center. An internationally renowned clinician scientist, clinician, and technical innovator, he has created a legacy of multidisciplinary teams using engineering and AI to tackle the most pressing challenges in brain disease.

Sydney Cash, MD PhD

Co-Founder

Syd is an Associate Professor at Harvard Medical School and directs the Center for Neurotechnology and Neurorecovery at MGH. He is a pioneer in the development of novel neurotechnology devices and is world-renowned for his impact on the clinical care of patients with epilepsy. His scientific research has produced groundbreaking discoveries into the physiology of seizures, sleep and memory.

Naveen Rao PhD

Former Head of AI, Intel

Naveen is an entrepreneur, technologist, and AI expert. He was previously the founder and CEO of Nervana Systems, a startup focused on hardware and software optimizations for neural networks. Nervana was acquired by Intel in 2016 and formed the basis of Intel AI, an organization he built and led. Naveen holds a PhD in Computational Neuroscience from Brown University.

Andy Beck MD, PhD

CEO, PathAI

Andy is the CEO and co-founder of PathAI, the world's leader in computational pathology. In his PhD work at Stanford, he developed one of the first machine-learning based systems for cancer pathology. Before PathAI, Andy completed his clinical training at Stanford and served as a faculty member in the Pathology Department at Beth Israel Deaconess Medical Center.